A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer-Reference-Cited by-同舟云学术

A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer

Published:2022-03-17 Issue:2 Volume:7 Page:437-443
ISSN:2378-8038
Container-title:Laryngoscope Investigative Otolaryngology
language:en
Short-container-title:Laryngoscope Investig Oto

Author:

Frankart Andrew J.¹^ORCID,Sadraei Nooshin Hashemi²,Huth Brad¹,Redmond Kevin P.¹,Barrett William L.¹,Kurtzweil Nicky³,Riaz Muhammad K.²,Wise‐Draper Trisha²,Rodriguez Cristina P.⁴,Adelstein David J.⁵,Takiar Vinita¹⁶^ORCID

Affiliation:

1. Department of Radiation Oncology University of Cincinnati Cincinnati Ohio USA

2. Division of Hematology/Oncology University of Cincinnati Cincinnati Ohio USA

3. University of Cincinnati Cancer Center Cincinnati Ohio USA

4. Division of Oncology, Department of Medicine University of Washington Seattle Washington USA

5. Department of Hematology and Medical Oncology Cleveland Clinic Taussig Cancer Institute Cleveland Ohio USA

6. Cincinnati VA Medical Center Cincinnati Ohio USA

Funder

Merck Sharp and Dohme

U.S. Department of Veterans Affairs

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/lio2.780

Reference25 articles.

1. Cancer statistics, 2017

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Risk for Occurrence of Laryngeal Cancer Among Current Cigarette Smokers

4. Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer

5. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competing risk models versus traditional Cox models for prognostic factors’ prediction and care recommendation in patients with advanced laryngeal squamous carcinoma: a population-based study;European Archives of Oto-Rhino-Laryngology;2023-04-28

2. The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens;Technology in Cancer Research & Treatment;2023-01

3. Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects;Technology in Cancer Research & Treatment;2023-01

4. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted;International Journal of Molecular Sciences;2022-06-29